Cargando…

Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement

PURPOSE: Clinically important deterioration (CID) is a composite endpoint developed to quantify the impact of pharmacological treatment in clinical trials for Chronic Obstructive Pulmonary Disease (COPD), also showing a prognostic value. CID is defined as any of the following condition: forced expir...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzetti, Gian Marco, Ora, Josuel, Sepiacci, Arianna, Cazzola, Mario, Rogliani, Paola, Calzetta, Luigino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576506/
https://www.ncbi.nlm.nih.gov/pubmed/37841747
http://dx.doi.org/10.2147/COPD.S396945
_version_ 1785121132610846720
author Manzetti, Gian Marco
Ora, Josuel
Sepiacci, Arianna
Cazzola, Mario
Rogliani, Paola
Calzetta, Luigino
author_facet Manzetti, Gian Marco
Ora, Josuel
Sepiacci, Arianna
Cazzola, Mario
Rogliani, Paola
Calzetta, Luigino
author_sort Manzetti, Gian Marco
collection PubMed
description PURPOSE: Clinically important deterioration (CID) is a composite endpoint developed to quantify the impact of pharmacological treatment in clinical trials for Chronic Obstructive Pulmonary Disease (COPD), also showing a prognostic value. CID is defined as any of the following condition: forced expiratory volume in 1 s decrease ≥100 mL from baseline, and/or St. George’s Respiratory Questionnaire total score increase ≥4-unit from baseline, and/or the occurrence of a moderate-to-severe exacerbation of COPD. Although most COPD patients experience a clinical worsening as they get older, to date, no specific studies assessed the correlation between ageing and CID in COPD. Therefore, the aim of this study was to investigate the impact of ageing on CID in COPD patients. PATIENTS AND METHODS: Data obtained from 55219 COPD patients were extracted from 17 papers, mostly post-hoc analyses. A pairwise meta-analysis and a meta-regression analysis were performed according to PRISMA-P guidelines to quantify the impact of pharmacological therapy on CID and to determine whether ageing might modulate the risk of CID in COPD patients. RESULTS: Inhaled treatments resulted generally effective in reducing the risk of CID in COPD (relative risk: 0.81, 95% confidence interval 0.79–0.84; P < 0.001). The meta-regression analysis indicated a trend toward significance (P = 0.063) in the linear relationship between age and the risk of CID. Of note, age significantly (P < 0.05) increased the risk of CID when associated with lower post-bronchodilator FEV(1). These results were not affected by a significant risk of bias. CONCLUSION: This quantitative synthesis suggests that inhaled therapy is effective in reducing the risk of CID in COPD, although such a protective effect may be affected in older patients with impaired lung function. Further studies specifically designed on CID in COPD are needed to confirm these results.
format Online
Article
Text
id pubmed-10576506
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-105765062023-10-15 Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement Manzetti, Gian Marco Ora, Josuel Sepiacci, Arianna Cazzola, Mario Rogliani, Paola Calzetta, Luigino Int J Chron Obstruct Pulmon Dis Review PURPOSE: Clinically important deterioration (CID) is a composite endpoint developed to quantify the impact of pharmacological treatment in clinical trials for Chronic Obstructive Pulmonary Disease (COPD), also showing a prognostic value. CID is defined as any of the following condition: forced expiratory volume in 1 s decrease ≥100 mL from baseline, and/or St. George’s Respiratory Questionnaire total score increase ≥4-unit from baseline, and/or the occurrence of a moderate-to-severe exacerbation of COPD. Although most COPD patients experience a clinical worsening as they get older, to date, no specific studies assessed the correlation between ageing and CID in COPD. Therefore, the aim of this study was to investigate the impact of ageing on CID in COPD patients. PATIENTS AND METHODS: Data obtained from 55219 COPD patients were extracted from 17 papers, mostly post-hoc analyses. A pairwise meta-analysis and a meta-regression analysis were performed according to PRISMA-P guidelines to quantify the impact of pharmacological therapy on CID and to determine whether ageing might modulate the risk of CID in COPD patients. RESULTS: Inhaled treatments resulted generally effective in reducing the risk of CID in COPD (relative risk: 0.81, 95% confidence interval 0.79–0.84; P < 0.001). The meta-regression analysis indicated a trend toward significance (P = 0.063) in the linear relationship between age and the risk of CID. Of note, age significantly (P < 0.05) increased the risk of CID when associated with lower post-bronchodilator FEV(1). These results were not affected by a significant risk of bias. CONCLUSION: This quantitative synthesis suggests that inhaled therapy is effective in reducing the risk of CID in COPD, although such a protective effect may be affected in older patients with impaired lung function. Further studies specifically designed on CID in COPD are needed to confirm these results. Dove 2023-10-10 /pmc/articles/PMC10576506/ /pubmed/37841747 http://dx.doi.org/10.2147/COPD.S396945 Text en © 2023 Manzetti et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Manzetti, Gian Marco
Ora, Josuel
Sepiacci, Arianna
Cazzola, Mario
Rogliani, Paola
Calzetta, Luigino
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
title Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
title_full Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
title_fullStr Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
title_full_unstemmed Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
title_short Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
title_sort clinically important deterioration (cid) and ageing in copd: a systematic review and meta-regression analysis according to prisma statement
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576506/
https://www.ncbi.nlm.nih.gov/pubmed/37841747
http://dx.doi.org/10.2147/COPD.S396945
work_keys_str_mv AT manzettigianmarco clinicallyimportantdeteriorationcidandageingincopdasystematicreviewandmetaregressionanalysisaccordingtoprismastatement
AT orajosuel clinicallyimportantdeteriorationcidandageingincopdasystematicreviewandmetaregressionanalysisaccordingtoprismastatement
AT sepiacciarianna clinicallyimportantdeteriorationcidandageingincopdasystematicreviewandmetaregressionanalysisaccordingtoprismastatement
AT cazzolamario clinicallyimportantdeteriorationcidandageingincopdasystematicreviewandmetaregressionanalysisaccordingtoprismastatement
AT roglianipaola clinicallyimportantdeteriorationcidandageingincopdasystematicreviewandmetaregressionanalysisaccordingtoprismastatement
AT calzettaluigino clinicallyimportantdeteriorationcidandageingincopdasystematicreviewandmetaregressionanalysisaccordingtoprismastatement